{
  "id": "d769de3b142b536a",
  "title": "STAT+: Compass says its psilocybin drug helped patients with severe depression in two trials",
  "description": "COMP360 could be the first psilocybin-based medicine to win approval.",
  "content": "COMP360 could be the first psilocybin-based medicine to win approval.",
  "source": "STAT",
  "source_url": "https://www.statnews.com/2026/02/17/compass-pathways-comp360-psilocybin-severe-depression-trial-results/?utm_campaign=rss",
  "published_at": "2026-02-17T11:30:00+00:00",
  "fetched_at": "2026-02-18T00:30:07.542614+00:00",
  "category": "health_biotech",
  "subcategory": null,
  "keywords": [
    "drug"
  ],
  "location": null,
  "raw_data": {
    "title": "STAT+: Compass says its psilocybin drug helped patients with severe depression in two trials",
    "description": "COMP360 could be the first psilocybin-based medicine to win approval.",
    "url": "https://www.statnews.com/2026/02/17/compass-pathways-comp360-psilocybin-severe-depression-trial-results/?utm_campaign=rss",
    "published": "2026-02-17T11:30:00+00:00",
    "source": "STAT"
  }
}